1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
3
|
Pasquinelli AE: MicroRNAs and their
targets: Recognition, regulation and an emerging reciprocal
relationship. Nat Rev Genet. 13:271–282. 2012. View Article : Google Scholar : PubMed/NCBI
|
4
|
Rupaimoole R and Slack FJ: MicroRNA
therapeutics: Towards a new era for the management of cancer and
other diseases. Nat Rev Drug Discov. 16:203–222. 2017. View Article : Google Scholar : PubMed/NCBI
|
5
|
Li Y and Wang X: Role of long noncoding
RNAs in malignant disease (Review). Mol Med Rep. 13:1463–1469.
2016. View Article : Google Scholar : PubMed/NCBI
|
6
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
7
|
Qu S, Yang X, Li X, Wang J, Gao Y, Shang
R, Sun W, Dou K and Li H: Circular RNA: A new star of noncoding
RNAs. Cancer Lett. 365:141–148. 2015. View Article : Google Scholar : PubMed/NCBI
|
8
|
Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J,
Chen D, Gu J, He X and Huang S: Circular RNA is enriched and stable
in exosomes: A promising biomarker for cancer diagnosis. Cell Res.
25:981–984. 2015. View Article : Google Scholar : PubMed/NCBI
|
9
|
Guo S, Xu X, Ouyang Y, Wang Y, Yang J, Yin
L, Ge J and Wang H: Microarray expression profile analysis of
circular RNAs in pancreatic cancer. Mol Med Rep. 17:7661–7671.
2018.PubMed/NCBI
|
10
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Liu BH, Zhang BB, Liu XQ, Zheng S, Dong KR
and Dong R: Expression profiling identifies circular RNA signature
in hepatoblastoma. Cell Physiol Biochem. 45:706–719. 2018.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Qian Y, Lu Y, Rui C, Qian Y, Cai M and Jia
R: Potential significance of circular RNA in human placental tissue
for patients with preeclampsia. Cell Physiol Biochem. 39:1380–1390.
2016. View Article : Google Scholar : PubMed/NCBI
|
13
|
Yang X, Yuan W, Tao J, Li P, Yang C, Deng
X, Zhang X, Tang J, Han J, Wang J, et al: Identification of
circular RNA signature in bladder cancer. J Cancer. 8:3456–3463.
2017. View Article : Google Scholar : PubMed/NCBI
|
14
|
Li M, Liu Y, Zhang X, Liu J and Wang P:
Transcriptomic analysis of high-throughput sequencing about
circRNA, lncRNA and mRNA in bladder cancer. Gene. 677:189–197.
2018. View Article : Google Scholar : PubMed/NCBI
|
15
|
Li P, Yang X, Yuan W, Yang C, Zhang X, Han
J, Wang J, Deng X, Yang H, Li P, et al: CircRNA-cdr1as exerts
anti-oncogenic functions in bladder cancer by sponging
MicroRNA-135a. Cell Physiol Biochem. 46:1606–1616. 2018. View Article : Google Scholar : PubMed/NCBI
|
16
|
Zhong Z, Huang M, Lv M, He Y, Duan C,
Zhang L and Chen J: Circular RNA MYLK as a competing endogenous RNA
promotes bladder cancer progression through modulating VEGFA/VEGFR2
signaling pathway. Cancer Lett. 403:305–317. 2017. View Article : Google Scholar : PubMed/NCBI
|
17
|
Xie F, Li Y, Wang M, Huang C, Tao D, Zheng
F, Zhang H, Zeng F, Xiao X and Jiang G: Circular RNA BCRC-3
suppresses bladder cancer proliferation through miR-182-5p/p27
axis. Mol Cancer. 17:1442018. View Article : Google Scholar : PubMed/NCBI
|
18
|
Gou Q, Wu K, Zhou JK, Xie Y, Liu L and
Peng Y: Profiling and bioinformatic analysis of circular RNA
expression regulated by c-Myc. Oncotarget. 8:71587–71596. 2017.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Zhong Z, Lv M and Chen J: Screening
differential circular RNA expression profiles reveals the
regulatory role of circTCF25-miR-103a-3p/miR-107-CDK6 pathway in
bladder carcinoma. Sci Rep. 6:309192016. View Article : Google Scholar : PubMed/NCBI
|
20
|
Zhu Z, Xu T, Wang L, Wang X, Zhong S, Xu C
and Shen Z: MicroRNA-145 directly targets the insulin-like growth
factor receptor I in human bladder cancer cells. FEBS Lett.
588:3180–3185. 2014. View Article : Google Scholar : PubMed/NCBI
|
21
|
Wang K, Long B, Liu F, Wang JX, Liu CY,
Zhao B, Zhou LY, Sun T, Wang M, Yu T, et al: A circular RNA
protects the heart from pathological hypertrophy and heart failure
by targeting miR-223. Eur Heart J. 37:2602–2611. 2016. View Article : Google Scholar : PubMed/NCBI
|
22
|
Zheng Q, Bao C, Guo W, Li S, Chen J, Chen
B, Luo Y, Lyu D, Li Y, Shi G, et al: Circular RNA profiling reveals
an abundant circHIPK3 that regulates cell growth by sponging
multiple miRNAs. Nat Commun. 7:112152016. View Article : Google Scholar : PubMed/NCBI
|
23
|
Jin P, Huang Y, Zhu P, Zou Y, Shao T and
Wang O: CircRNA circHIPK3 serves as a prognostic marker to promote
glioma progression by regulating miR-654/IGF2BP3 signaling. Biochem
Biophys Res Commun. 503:1570–1574. 2018. View Article : Google Scholar : PubMed/NCBI
|
24
|
Li Y, Wan B, Liu L, Zhou L and Zeng Q:
Circular RNA circMTO1 suppresses bladder cancer metastasis by
sponging miR-221 and inhibiting epithelial-to-mesenchymal
transition. Biochem Biophys Res Commun. 508:991–996. 2019.
View Article : Google Scholar : PubMed/NCBI
|